SYNTHESIS AND EVALUATION OF THE THIOSEMICARBAZONE, DITHIOCARBAZONATE, AND 2'-PYRAZINYLHYDRAZONE OF PYRAZINECARBOXALDEHYDE AS AGENTS FOR THE TREATMENT OF IRON OVERLOAD

被引:31
作者
SPINGARN, NE
SARTORELLI, AC
机构
[1] YALE UNIV,SCH MED,CTR COMPREHENS CANC,DEPT PHARMACOL,NEW HAVEN,CT 06510
[2] YALE UNIV,SCH MED,CTR COMPREHENS CANC,PROGRAM DEV THERAPEUT,NEW HAVEN,CT 06510
关键词
D O I
10.1021/jm00197a007
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three prototype tridentate ligands (i.e., pyrazinecarboxaldehyde thiosemicarbazone, sodium pyrazinecarboxaldehyde dithiocarbazonate, and pyrazinecarboxaldehyde 2ʹ-pyrazinylhydrazone) were prepared and evaluated for their relative abilities to remove iron from model systems designed to mimic particular aspects of chronic transfusional iron overload. These compounds were synthesized by condensation of pyrazinecarboxaldehyde with the appropriate substituted hydrazide. Iron-binding properties were determined, and the ability to remove iron from the proteins transferrin and ferritin was ascertained. An in vivo model system employing iron-loaded mice was used to demonstrate that all three compounds were effective at reducing tissue iron levels. © 1979, American Chemical Society. All rights reserved.
引用
收藏
页码:1314 / 1316
页数:3
相关论文
共 25 条
[1]   COMPARATIVE STUDIES OF ANTINEOPLASTIC ACTIVITY OF 5-HYDROXY-2-FORMYLPYRIDINE THIOSEMICARBAZONE AND ITS SELENO-SEMICARBAZONE, GUANYLHYDRAZONE AND SEMICARBAZONE ANALOGS [J].
AGRAWAL, KC ;
BOOTH, BA ;
MICHAUD, RL ;
MOORE, EC ;
SARTORELLI, AC .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (17) :2421-2429
[2]  
ANTHOLINE W, 1977, MOL PHARMACOL, V13, P89
[3]   PHOTOMETRIC DETERMINATION OF COMPOSITION AND CONDITIONAL STABILITY CONSTANTS OF COMPLEXES AMBN [J].
BUDESINSKY, B .
JOURNAL OF INORGANIC & NUCLEAR CHEMISTRY, 1969, 31 (05) :1345-+
[4]  
CANO JM, 1971, AN QUIM-INT, V67, P299
[5]   PREPARATION OF FE-59 LABELLED TRANSFERRIN FOR FERROKINETIC STUDIES [J].
CAVILL, I .
JOURNAL OF CLINICAL PATHOLOGY, 1971, 24 (05) :472-&
[6]  
DECONTI RC, 1972, CANCER RES, V32, P1455
[7]  
FRENCH FA, 1965, FED PROC, V24, P402
[8]  
GRALLA EJ, 1975, P S DEV IR CHEL CLIN, P229
[9]  
HERSHKO C, 1975, J LAB CLIN MED, V85, P913
[10]  
Hyman C B, 1976, Birth Defects Orig Artic Ser, V12, P43